Revvity 将来の成長

NYSE:RVTY - アナリストの将来予測と過去の財務データ ( )USD Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
12/31/2026	3,128	398	740	830	11
12/31/2025	2,913	330	675	759	15
12/31/2024	2,757	269	562	651	13
9/29/2024	2,722	258	564	651	N/A
6/30/2024	2,708	197	383	469	N/A
3/31/2024	2,726	183	97	175	N/A
12/31/2023	2,751	180	10	91	N/A
10/1/2023	2,796	213	-50	34	N/A
7/2/2023	2,837	250	153	227	N/A
4/2/2023	3,024	353	380	460	N/A
1/1/2023	3,312	513	594	680	N/A
10/2/2022	3,599	599	790	876	N/A
7/3/2022	3,748	637	932	1,030	N/A
4/3/2022	3,483	694	1,122	1,220	N/A
1/2/2022	3,828	889	1,325	1,411	N/A
10/3/2021	4,155	1,086	1,478	1,557	N/A
7/4/2021	4,257	1,155	1,380	1,455	N/A
4/4/2021	4,438	1,074	1,234	1,306	N/A
1/3/2021	2,663	631	829	892	N/A
10/4/2020	3,234	412	545	625	N/A
7/5/2020	2,977	294	444	521	N/A
4/5/2020	2,887	226	352	429	N/A
12/29/2019	2,884	228	282	363	N/A
9/29/2019	2,835	235	217	308	N/A
6/30/2019	2,802	251	199	294	N/A
3/31/2019	2,783	247	225	320	N/A
12/30/2018	2,778	237	218	311	N/A
9/30/2018	2,663	128	203	280	N/A
7/1/2018	2,543	149	N/A	245	N/A
4/1/2018	2,387	147	N/A	220	N/A
12/31/2017	2,257	157	N/A	288	N/A
10/1/2017	2,182	258	N/A	309	N/A
7/2/2017	2,142	215	N/A	324	N/A
4/2/2017	2,132	210	N/A	372	N/A
1/1/2017	2,116	216	N/A	351	N/A
10/2/2016	1,999	198	N/A	327	N/A
7/3/2016	2,048	199	N/A	314	N/A
4/3/2016	2,076	190	N/A	281	N/A
1/3/2016	2,105	189	N/A	287	N/A
10/4/2015	2,263	176	N/A	258	N/A
6/28/2015	2,241	164	N/A	261	N/A
3/29/2015	2,234	167	N/A	252	N/A
12/28/2014	2,070	130	N/A	282	N/A
9/28/2014	2,221	203	N/A	257	N/A
6/29/2014	2,201	201	N/A	242	N/A
3/30/2014	2,185	176	N/A	215	N/A
12/29/2013	2,158	174	N/A	159	N/A

アナリストによる今後の成長予測

収入対貯蓄率: RVTYの予測収益成長率 (年間19.8% ) は貯蓄率 ( 2.6% ) を上回っています。

収益対市場: RVTYの収益 ( 19.8% ) はUS市場 ( 15.4% ) よりも速いペースで成長すると予測されています。

高成長収益: RVTYの収益は増加すると予測されていますが、大幅には増加しません。

収益対市場: RVTYの収益 ( 6% ) US市場 ( 9% ) よりも低い成長が予測されています。

高い収益成長: RVTYの収益 ( 6% ) 20%よりも低い成長が予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: RVTYの自己資本利益率は、3年後には低くなると予測されています ( 7.8 %)。

Revvity 将来の成長

Future 基準チェック /26

主要情報

今後の成長に関する最新情報

Revvity, Inc. Updates Earnings Guidance for the Full Year 2024

Price target increased by 8.2% to US$134

Revvity, Inc. Updates Earnings Guidance for the Full Year 2024

Revvity, Inc. Updates Earnings Guidance for the Full Year 2024

Revvity, Inc. Re-Affirms Earnings Guidance for the Full Year 2024

Price target increased by 8.9% to US$122

Recent updates

Scale Biosciences and Revvity's BioLegend Launch First-Of-Its-Kind Solution for High Parameter Protein Profiling of Single Cells

We Think Revvity's (NYSE:RVTY) Healthy Earnings Might Be Conservative

Dividend of US$0.07 announced

Revvity, Inc. (NYSE:RVTY) announces an Equity Buyback for $1,000 million worth of its shares.

Revvity, Inc. Updates Earnings Guidance for the Full Year 2024

Third quarter 2024 earnings: EPS exceeds analyst expectations

Revvity, Inc. Declares Quarterly Dividend, Payable on February 7, 2025

Here's Why Revvity (NYSE:RVTY) Can Manage Its Debt Responsibly

Upcoming dividend of US$0.07 per share

Revvity, Inc. to Report Q3, 2024 Results on Nov 04, 2024

Getting In Cheap On Revvity, Inc. (NYSE:RVTY) Might Be Difficult

Second quarter 2024 earnings: EPS misses analyst expectations

Price target increased by 8.2% to US$134

Revvity, Inc. Updates Earnings Guidance for the Full Year 2024

Dividend of US$0.07 announced

Revvity Board Declares Quarterly Dividend, Payable on November 8, 2024

When Should You Buy Revvity, Inc. (NYSE:RVTY)?

Upcoming dividend of US$0.07 per share

Revvity, Inc. to Report Q2, 2024 Results on Jul 29, 2024

Revvity: Continued Struggles, 2024 Becoming A Lost Year

Is Revvity (NYSE:RVTY) Using Too Much Debt?

First quarter 2024 earnings: EPS misses analyst expectations

Revvity, Inc. Updates Earnings Guidance for the Full Year 2024

Dividend of US$0.07 announced

Revvity, Inc. Declares Quarterly Dividend, Payable on August 9, 2024

Revvity Unveils A New Era of Automated Tuberculosis Testing

Upcoming dividend of US$0.07 per share

Revvity, Inc. to Report Q1, 2024 Results on Apr 29, 2024

Why We're Not Concerned About Revvity, Inc.'s (NYSE:RVTY) Share Price

Revvity: Enter Now As Reorganization Takes Shape

Revvity, Inc. Re-Affirms Earnings Guidance for the Full Year 2024

Revvity Signals Software Introduces Signals ChemDraw Offering to Set New Standard for Cloud-Native Chemistry Communication

Revvity, Inc. Introduces New Workflow to Accelerate Newborn Sequencing Research

We Think Revvity (NYSE:RVTY) Can Stay On Top Of Its Debt

Investors Can Find Comfort In Revvity's (NYSE:RVTY) Earnings Quality

Revvity Signals Software Unveils Signals Clinical Solution to Accelerate Critical Clinical Trial Insights and Data-Driven Decisions

CEO, President & Director notifies of intention to sell stock

New minor risk - Earnings quality

Price target increased by 8.9% to US$122

Revvity Showcases Cutting-Edge Solutions at SLAS2024

Full year 2023 earnings: EPS exceeds analyst expectations

Revvity, Inc. Provides Revenue Guidance for the Full Year of 2024

Dividend of US$0.07 announced

Revvity, Inc., Annual General Meeting, Apr 23, 2024

Revvity, Inc. Announces Board Elections, Effective February 1, 2024

Should You Think About Buying Revvity, Inc. (NYSE:RVTY) Now?

Upcoming dividend of US$0.07 per share at 0.3% yield

Revvity, Inc. to Report Q4, 2023 Results on Feb 01, 2024

Revvity, Inc. Provides Revenue Guidance for the Fourth Quarter 2023

An Intrinsic Calculation For Revvity, Inc. (NYSE:RVTY) Suggests It's 49% Undervalued

Revvity: More Than A Name Change Is Needed For PerkinElmer

Why We're Not Concerned About Revvity, Inc.'s (NYSE:RVTY) Share Price

Revvity, Inc. Launches EONIS Q System, Enabling Faster, Simplified Newborn Screening for SMA and SCID

Revvity, Inc. Launches EONIS Q System, Enabling Faster, Simplified Newborn Screening for SMA and SCID

Consensus EPS estimates fall by 15%

Price target decreased by 22% to US$107

Revvity, Inc. Provides Earnings Guidance for the Full Year 2023

New minor risk - Earnings quality

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

Revvity Board Declares Quarterly Dividend, Payable on February 9, 2024

Upcoming dividend of US$0.07 per share at 0.3% yield

Revvity, Inc. to Report Q3, 2023 Results on Oct 30, 2023

Is Revvity (NYSE:RVTY) Using Too Much Debt?

Revvity: Recent Investments, Acquisitions, Not Pulling Economic Weight (Rating Downgrade)

Revvity Expands Access to Base Editing Technology with Aim to Accelerate Discovery to Cure

At US$108, Is Revvity, Inc. (NYSE:RVTY) Worth Looking At Closely?

Revvity, Inc. Unveils Several Next-Generation Preclinical Imaging Technologies to Help Scientists Drive Breakthrough Discoveries

An Intrinsic Calculation For Revvity, Inc. (NYSE:RVTY) Suggests It's 40% Undervalued

Revvity, Inc. Provides Earnings Guidance for the Full Year 2023